LGM

Logos Global Management Portfolio holdings

AUM $749M
This Quarter Return
+27.42%
1 Year Return
+18.94%
3 Year Return
+431.72%
5 Year Return
+481.1%
10 Year Return
AUM
$855M
AUM Growth
+$855M
Cap. Flow
+$19.6M
Cap. Flow %
2.3%
Top 10 Hldgs %
52.05%
Holding
71
New
17
Increased
11
Reduced
9
Closed
23
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
CMPS
51
Compass Pathways
CMPS
$424M
-1,159,030
Closed -$7.3M
COGT icon
52
Cogent Biosciences
COGT
$1.69B
-2,000,000
Closed -$21.6M
CYBN
53
Cybin
CYBN
$176M
-600,000
Closed -$5.33M
ENGN icon
54
enGene Holdings
ENGN
$236M
-800,000
Closed -$5.28M
FULC icon
55
Fulcrum Therapeutics
FULC
$351M
0
GLPG icon
56
Galapagos
GLPG
$2.07B
-800,000
Closed -$23M
IOBT icon
57
IO Biotech
IOBT
$104M
-493,827
Closed -$519K
IONS icon
58
Ionis Pharmaceuticals
IONS
$6.79B
-750,000
Closed -$30M
LCTX icon
59
Lineage Cell Therapeutics
LCTX
$267M
-5,000,000
Closed -$4.53M
NMRA icon
60
Neumora Therapeutics
NMRA
$280M
-100,000
Closed -$1.32M
NUVL icon
61
Nuvalent
NUVL
$5.52B
-75,000
Closed -$7.67M
NXTC icon
62
NextCure
NXTC
$13.5M
-2,500,000
Closed -$3.43M
RCKT icon
63
Rocket Pharmaceuticals
RCKT
$354M
-325,000
Closed -$6M
SLN
64
Silence Therapeutics
SLN
$227M
-200,000
Closed -$3.64M
SRPT icon
65
Sarepta Therapeutics
SRPT
$1.78B
-150,000
Closed -$18.7M
BOLD
66
Boundless Bio
BOLD
$25.1M
-58,903
Closed -$204K
SKYE icon
67
Skye Bioscience
SKYE
$108M
-100,000
Closed -$391K
ORKA
68
Oruka Therapeutics, Inc. Common Stock
ORKA
$554M
-257,330
Closed -$6.31M
BCAX
69
Bicara Therapeutics Inc. Common Stock
BCAX
$651M
-800,000
Closed -$20.4M
ADVM icon
70
Adverum Biotechnologies
ADVM
$64.6M
-416,666
Closed -$2.92M
AVTX icon
71
Avalo Therapeutics
AVTX
$122M
-539,079
Closed -$5.12M